The short version of regulatory status fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-14 and is reviewed periodically as new material appears.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
IUPAC organic nomenclature has three main parts: the substituents, carbon chain length, and chemical affix. The substituents are any functional groups tied to the main carbon chain. The main carbon chain is the longest possible continuous chain. The chemical affix denotes what type of molecule it is. For example, the ending ane conveys a single bonded carbon chain, as in "hexane" (C6H14). Another example of IUPAC organic nomenclature is cyclohexanol:
== Side effects == Common adverse reactions include nausea, headache, fatigue, vomiting, diarrhea, Anorexia (symptom) (loss of appetite), and insomnia (trouble sleeping). Rare but serious side effects include hypersensitivity reaction such as rash, elevated AST and ALT, depression, anxiety, fever/chills, URI, lactic acidosis, hypertriglyceridemia, and lipodystrophy.
She put out her hand, and measured the soothing drops into a glass; but as she did so, she knew they would be powerless against the supernatural lucidity of her brain. She had long since raised the dose to its highest limit, but to-night she felt she must increase it. She knew she took a slight risk in doing so—she remembered the chemist's warning. If sleep came at all, it might be a sleep without waking.In the James Bond films From Russia With Love and The Living Daylights, chloral hydrate is used as a knockout drug.
3-phosphoglycerate can be separated and measured using paper chromatography as well as with column chromatography and other chromatographic separation methods. It can be identified using both gas-chromatography and liquid-chromatography mass spectrometry and has been optimized for evaluation using tandem MS techniques. 2-Phosphoglyceric acid Calvin-Benson cycle Photosynthesis Ribulose 1,5-bisphosphate
== Sodium-23 == Sodium-23 is the sole natural isotope of sodium, with an atomic mass of 22.98976928. Because of this, sodium-23 is used in nuclear magnetic resonance in various research fields, including materials science and battery research. Sodium-23 relaxation has applications in studying cation-biomolecule interactions, intracellular and extracellular sodium, ion transport in batteries, and quantum information processing.
Sources: en.wikipedia.org
Regulatory agencies, such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), have established approval pathways to ensure biosimilar insulins meet the same quality, safety, and efficacy standards as reference products.
Saakashvili wrote: "And above all, it is a war over the kind of Europe our children will live in." Saakashvili further wrote on 14 August that Russia felt threatened by Georgia's desire to pursue freedom and the world "cannot allow Georgia to become the first victim of a new world order as imagined by Moscow." On 24 August 2008, Georgian president Mikheil Saakashvili made a televised appearance. He remembered his interactions with both Vladimir Putin and Dmitry Medvedev. Saakashvili said that Putin had told him in the aftermath of the 2004 Adjara crisis: "Now remember, in Adjara we did not intervene, but you won't have any gifts from us in South Ossetia or Abkhazia." Saakashvili suggested that Russia was planning the invasion of Georgia since 2007. He said that although there were casualties among the Georgian forces on late 7 August 2008 and the Georgian defense minister was asking him to respond with artillery, his position was that Georgia "could not open fire whatever happened". Saakashvili also said that the Russian army had moved into South Ossetia before 8 August 2008 and Georgian pilots observed that "whole area [near the Roki Tunnel] was full of Russian military" on the morning of 8 August which could not be deployed "in a matter of hours; this is unreal." He criticized the West's inability to detect this movement via the satellites.
==== Blood-cell formation ==== The specificity of the human immune-cell repertoire is what allows the human body to defend itself from rapidly adapting antigens. However, the immune system is vulnerable to degradation upon the pathogenesis of disease, and because of the critical role that it plays in overall defense, its degradation is often fatal to the organism as a whole. Diseases of hematopoietic cells are diagnosed and classified via a subspecialty of pathology known as hematopathology. The specificity of the immune cells is what allows recognition of foreign antigens, causing further challenges in the treatment of immune disease. Identical matches between donor and recipient are no longer required for successful transplantation. Rather, haploidentical matches have facilitated numerous transplants, given improvements in post-transplant immunosuppressive regimens. Research using both hematopoietic adult stem cells and embryonic stem cells has provided insight into the possible mechanisms and methods of treatment for many of these ailments. Fully mature human red blood cells may be generated ex vivo by hematopoietic stem cells (HSCs), which are precursors of red blood cells. In this process, HSCs are grown together with stromal cells, creating an environment that mimics the conditions of bone marrow, the natural site of red-blood-cell growth. Erythropoietin, a growth factor, is added, coaxing the stem cells to complete terminal differentiation into red blood cells.
=== Comic Books === Comics published during the Cold War provided both entertainment and political commentary. Themes of foreign wars, radiation, and social injustices were prevalent within the genre. Comics like Fantastic Four show American's relationship to the nuclear family unit, while other comics like Spider-Man and The Incredible Hulk show societal fears related to nuclear power and its effects. Other comics were less focused on fantastical elements and instead set their stories within Cold War events. Marines In Action was a comic series that ran from 1955 to 1957 that focuses on fictional characters within the Korean War. These comics were pro-war, which was a common sentiment among military centered stories.Golgo 13, a Japanese comic published since October 1968 also portrayed Cold War events like Fall of the Berlin Wall and Tiananmen Square protests from the perspective of the protagonist, a professional hitman hired by different powers.
Trump's cabinet choices were described by news media as valuing personal loyalty over relevant experience, and for having a range of conflicting ideologies and "eclectic personalities". It was also described as the wealthiest administration in modern history, with over 13 billionaires chosen to take government posts. He nominated or appointed 23 former Fox News employees to his administration. Notably, Trump's nomination of Scott Bessent as Secretary of the Treasury made Bessent the highest ranking openly LGBTQ person to serve in the United States government. In March 2026, The Wall Street Journal reported that Trump was planning to fire Kristi Noem after a Senate Judiciary Committee hearing during which she was criticised for her actions during her term of office, including her handling of the killings of Renée Good and Alex Pretti, inappropriate relations with her advisor, Corey Lewandowski, and mismanagement of funds. On March 5, Trump announced her reassignment to a new position, "Special Envoy for The Shield of the Americas", and announced Oklahoma senator, Markwayne Mullin as her successor as the secretary of homeland security. Noem is the first Cabinet official to be removed from her post during Trump's second presidency.
Sources: en.wikipedia.org
=== Solution === Unmodified chitosan is generally insoluble in pure water, but dissolves in dilute acidic solutions (pH < 6). It is insoluble in most organic solvents. This is because chitosan behaves like a strong base, with its primary amine groups having a pKa of about 6.3 for the reaction R-NH+3 ⇌ R−NH2 + H+. When enough hydrogen ions are present, the amine group becomes protonated, giving it a positive charge. This allows water molecules to better "pick up" chitosan in the form of a water-soluble cationic polyelectrolyte. Chitosan readily forms soluble salts with many organic acid anions, including formate, acetate, lactate, malate, citrate, glyoxylate, pyruvate, glycolate, and ascorbate. Chitosan can also be dissolved in aqueous CO2, which is useful for minimizing excess acidity. The solubility and pKa of chitosan is affected by DD%. How the acetyl groups are distributed on the chain also matters. As a polyelectrolyte, the protonation behavior of chitosan is best described by Kachalsky's equation.
== Function == The protein is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Genetic deficiency of this enzyme results in an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy.
== In disease == Membrane proteins are the targets of over 50% of all modern medicinal drugs. Among the human diseases in which membrane proteins have been implicated are heart disease, Alzheimer's and cystic fibrosis.
== In plants == While most plant species are perennial, about 6% follow an annual life cycle, living for only one growing season. The annual life cycle has evolved in over 120 plant families across the entire angiosperm phylogeny. Notably, the prevalence of annual species increases under hot-dry summer conditions in different families including Asteraceae, Brassicaceae, Fabaceae, and Poaceae. Leaves have evolved multiple times - see Evolutionary history of plants. They have evolved not only in land plants, but also in various algae, like kelp. Prickles, thorns and spines are all modified plant tissues that have evolved to prevent or limit herbivory, these structures have evolved independently a number of times. Stimulant toxins: plants which are only distantly related to each other, such as coffee, tea, kola and yerba mate produce caffeine to deter predators. The aerial rootlets found in ivy (Hedera) are similar to those of the climbing hydrangea (Hydrangea petiolaris) and some other vines. These rootlets are not derived from a common ancestor but have the same function of clinging to whatever support is available. Flowering plants (Delphinium, Aerangis, Tropaeolum and others) from different regions form tube-like spurs that contain nectar. This is why insects from one place sometimes can feed on plants from another place that have a structure like the flower, which is the traditional source of food for the animal.
Krebs (1900–1981), German-British biochemist, Nobel Prize in Physiology or Medicine (1953)for work on metabolic cycles Harold Kroto (1939–2016), English chemist, 1996 Nobel Prize in Chemistry for discovery of fullerenes Richard Kuhn (1900–1967), 1938 Nobel Prize in Chemistry for work on carotenoids and vitamins Eugenia Kumacheva (PhD 1986), Ukrainian-Canadian chemist with work on fundamental and applied polymers science, nanotechnology, microfluidics, and interface chemistry Theodore Kuwana, (1931–2022), American chemist, founder of the field of spectroelectrochemistry
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.